38725_US Nexxana Desire PT-141 Telehealth

Nexxana Desire is a prescription telehealth treatment for low sexual desire in women, built around bremelanotide (PT-141) — an FDA-approved molecule delivered as a small, on-demand subcutaneous injection taken 45–60 minutes before intimacy. Rather than a supplement, it is a compounded prescription product accessed online: the patient chooses a plan and completes a health intake, a US-licensed provider reviews it and prescribes if appropriate, and a licensed 503A compounding pharmacy ships the pre-mixed vial in plain, discreet packaging. It is non-hormonal, taken only when wanted, and arrives ready to use with syringes and alcohol pads included.

The product is aimed at adult women experiencing low or absent sexual desire — whether after pregnancy, through perimenopause, on an SSRI, under chronic stress/burnout, or seeking a non-hormonal option — who want an on-demand, brain-pathway approach rather than a daily pill, hormone therapy, or a blood-flow drug.

Benefits

Approved-molecule treatment developed and studied specifically in women (not adapted from a men's product).

Works centrally on the melanocortin pathway — the brain circuitry that generates desire — not on blood flow.

Non-hormonal, with no daily dosing and no weeks-long buildup.

On-demand: taken only when wanted, with onset within about 45–60 minutes.

Compatible with SSRIs (acts on melanocortin, not serotonin).

Arrives pre-mixed and ready to inject via an insulin-thin needle; discreet, unmarked shipping; ongoing provider support; HSA/FSA eligible, no insurance needed.

How It Works

Online intake — a short (about three-minute) online health questionnaire.

Physician review — a US-licensed physician reviews the application and personalizes the dose.

Discreet delivery — if approved, a certified US compounding pharmacy ships the prescription in a plain, unmarked box.

Checkout event fires on order placement - non-payable

Conversion fires on shipment - payable

Payouts:

1 month - $80

3 months - $160

6 months - $260

12 months - $380

Creative materials: https://drive.google.com/drive/folders/1VAUWefVaQ30CKolWWKEX2ll8Jr2Ak1lk?usp=sharing

Restrictions:

• US only, all 50 states

• No incentivized traffic

• No trademark or brand bidding on NEOLISE, Nexxana, or product names

• No disease claims, no "FDA approved," no guaranteed results, no specific weight loss numbers

• No before/after imagery

• No comparison to Ozempic, Wegovy, Mounjaro or any branded drug by name

• Desire is women 18+ only, no adult or dating placements